AngioDynamics to Present at the J.P. Morgan Healthcare Conference

ANGO 01.06.2025

SERA-AI Powered Highlights
Date of Upcoming Event:2025-01-16
Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference
Full Press ReleaseSEC FilingsOur ANGO Tweets

About Gravity Analytica

Recent News

  • 01.16.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.13.2025 - AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
  • 01.08.2025 - Virtual NanoKnife Investor Event

Recent Filings

  • 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.16.2025 - 8-K Current report
  • 01.16.2025 - 144 Report of proposed sale of securities

LATHAM, N.Y.--(BUSINESS WIRE)--Jan. 6, 2025--AngioDynamics, Inc.(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced thatJim Clemmer, President and Chief Executive Officer, andStephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 43rdAnnualJ.P. Morgan Healthcare Conferenceat7:30 a.m. PTonThursday, January 16, 2025.

A live webcast of the fireside chat will be accessible through the “Investors” section of the Company’s website atwww.angiodynamics.comand will be available for replay following the event.

AboutAngioDynamics, Inc.

AngioDynamicsis a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visitwww.angiodynamics.com.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20250106392109/en/

Investors:

AngioDynamics, Inc.Stephen Trowbridge, Executive Vice President & CFO(518) 795-1408

Source:AngioDynamics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com